Some other studies have proven that melatonin in a hypoxic environment inhibits pro-apoptotic proteins and caspase-3 [48] and, moreover, inhibits proliferation in cancer cells, like prostate [49] and melanoma [50], through the melatonin receptor pathway. Here, CASP3 is linked to melanoma.